GDF2 and Pulmonary arterial hypertension associated with portal hypertension: Importantly, BMPR2 down-regulation contributes to hyper-proliferative, apoptosis resistant phenotype in PAH pulmonary vascular cells31–34, and BMP9 is deficient in portopulmonary hypertension and is a biomarker for transplant-free survival35.